UBS Group’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.22M | Sell |
752,679
-202
| -0% | -$1.19K | ﹤0.01% | 4120 |
|
|
2026
Q1 | $3.09M | Sell |
752,881
-128,488
| -15% | -$623K | ﹤0.01% | 4568 |
|
|
2025
Q4 | $5.86M | Sell |
881,369
-148,747
| -14% | -$1.01M | ﹤0.01% | 3869 |
|
|
2025
Q3 | $6.32M | Sell |
1,030,116
-46,468
| -4% | -$362K | ﹤0.01% | 3794 |
|
|
2025
Q2 | $9.92M | Buy |
1,076,584
+122,925
| +13% | +$1.26M | ﹤0.01% | 3089 |
|
|
2025
Q1 | $11.5M | Sell |
953,659
-139,746
| -13% | -$1.83M | ﹤0.01% | 2881 |
|
|
2024
Q4 | $12.1M | Buy |
1,093,405
+448,104
| +69% | +$6.3M | ﹤0.01% | 2849 |
|
|
2024
Q3 | $10.5M | Sell |
645,301
-7,570
| -1% | -$106K | ﹤0.01% | 2321 |
|
|
2024
Q2 | $7.08M | Buy |
652,871
+81,689
| +14% | +$1M | ﹤0.01% | 2525 |
|
|
2024
Q1 | $8M | Sell |
571,182
-95,103
| -14% | -$1.24M | ﹤0.01% | 2476 |
|
|
2023
Q4 | $7.02M | Sell |
666,285
-108,096
| -14% | -$967K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $7.08M | Sell |
774,381
-186,064
| -19% | -$1.67M | ﹤0.01% | 2257 |
|
|
2023
Q2 | $6.98M | Buy |
960,445
+941,076
| +4,859% | +$8.12M | ﹤0.01% | 2264 |
|
|
2023
Q1 | $164K | Buy |
19,369
+4,733
| +32% | +$42.8K | ﹤0.01% | 5544 |
|
|
2022
Q4 | $110K | Buy |
14,636
+12,536
| +597% | +$97.1K | ﹤0.01% | 6016 |
|
|
2022
Q3 | $17K | Sell |
2,100
-2,500
| -54% | -$26.5K | ﹤0.01% | 7587 |
|
|
2022
Q2 | $53K | Sell |
4,600
-9,571
| -68% | -$113K | ﹤0.01% | 5863 |
|
|
2022
Q1 | $159K | Buy |
14,171
+5,340
| +60% | +$45.5K | ﹤0.01% | 5540 |
|
|
2021
Q4 | $57K | Buy |
8,831
+1,446
| +20% | +$9.92K | ﹤0.01% | 6776 |
|
|
2021
Q3 | $57K | Sell |
7,385
-7,251
| -50% | -$75K | ﹤0.01% | 6227 |
|
|
2021
Q2 | $185K | Sell |
14,636
-838
| -5% | -$9.21K | ﹤0.01% | 5410 |
|
|
2021
Q1 | $201K | Sell |
15,474
-4,085
| -21% | -$37.7K | ﹤0.01% | 5481 |
|
|
2020
Q4 | $66K | Sell |
19,559
-33,078
| -63% | -$124K | ﹤0.01% | 5954 |
|
|
2020
Q3 | $206K | Sell |
52,637
-12,913
| -20% | -$47.2K | ﹤0.01% | 4780 |
|
|
2020
Q2 | $347K | Buy |
65,550
+12,325
| +23% | +$56.8K | ﹤0.01% | 4412 |
|
|
2020
Q1 | $221K | Sell |
53,225
-30,340
| -36% | -$257K | ﹤0.01% | 4646 |
|
|
2019
Q4 | $1.02M | Buy |
83,565
+4,076
| +5% | +$57.5K | ﹤0.01% | 4196 |
|
|
2019
Q3 | $1.24M | Buy |
79,489
+16,506
| +26% | +$271K | ﹤0.01% | 3771 |
|
|
2019
Q2 | $921K | Sell |
62,983
-29,672
| -32% | -$588K | ﹤0.01% | 3816 |
|
|
2019
Q1 | $2.09M | Buy |
92,655
+90,220
| +3,705% | +$1.95M | ﹤0.01% | 2947 |
|
|
2018
Q4 | $29K | Sell |
2,435
-1,208
| -33% | -$17.2K | ﹤0.01% | 6505 |
|
|
2018
Q3 | $68K | Buy |
3,643
+3,115
| +590% | +$67.5K | ﹤0.01% | 5917 |
|
|
2018
Q2 | $15K | Sell |
528
-322
| -38% | -$5.69K | ﹤0.01% | 6885 |
|
|
2018
Q1 | $8K | Buy |
+850
| New | +$9.73K | ﹤0.01% | 6999 |
|
Other funds holding EOLS
NCM
B
FLSM
PA
SCM
UBS Group's EOLS Position: Q2 2026 in Review
UBS Group reduced its Evolus (EOLS) stake by 0.03% in Q2 2026, selling an estimated $1.19K and leaving 752,679 shares worth $5.22M. The position accounts for ﹤0.01% of the portfolio, ranked #4120.
UBS Group first reported a position in EOLS in Q1 2018 and has held it in 34 quarters since. The position peaked at $12.1M in Q4 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- UBS Group held 752,679 shares of Evolus worth $5.22M as of Q2 2026.
- UBS Group sold 202 Evolus shares in Q2 2026, an estimated $1.19K.
- Evolus made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4120 holding.
- UBS Group first reported a position in Evolus in Q1 2018 and has held it in 34 quarters since.
- UBS Group's Evolus position peaked at $12.1M in Q4 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.